Skip to main content

Metabolic

2020 ACR Gout Management Guideline

Jul 03, 2020

In May, the American College of Rheumatology (ACR) released the"2020 Guideline for the Management of Gout"reflecting new clinical evidence since the last guideline published in 2012.



The guideline puts forth 42 recommendations, including 16 strong recommendations, based in 52 PICO

Read Article
#EULAR2020 #op0192 UK Biobank and IMPALA studies: metabolic body composition of PsA pts w/increased VAT,ectopic liver fat distribution & ⬆️ abdominal fat index associated w/increased risk of CHD&T2DM @RheumNow https://t.co/CwwAB2yUid
Olga Petryna DrPetryna ( View Tweet)
Jun 07, 2020

RheumNow Podcast – In Times of Trouble (4.24.20)

Apr 24, 2020

Dr Jack Cush reviews the news, journal reports, twitter feed and COVID developments from the past week on RheumNow.com

Read Article

Lower Risk of Diabetes with Abatacept

Apr 20, 2020

 Patients with rheumatoid arthritis (RA) treated with abatacept (Orencia) had a lower risk of developing diabetes mellitus compared with those receiving certain tumor necrosis factor (TNF) inhibitors, a large cohort study suggested.

Read Article

Updates on Psoriatic Arthritis at ACR 2018

Mar 05, 2020

I think 2018 was the year that belonged to psoriatic arthritis (although some may argue in favor of immune conditions induced by Checkpoint inhibitors). Many years ago the late Professor Verna Wright in Leeds (UK) was a lone voice for many years describing the clinical subtypes of Psoriatic

Read Article

A Role for SGLT2 Inhibition in Gout?

Dec 17, 2019

The antidiabetic medication canagliflozin (Invokana) lowered serum urate and reduced the risk of gout flare in a post-hoc analysis of data from two large clinical trials.

In the CANVAS clinical trial program, which was funded by Janssen Research & Development and included more than

Read Article

ACR 2018 - Day 1 Report

Oct 11, 2019

Highlights from Tuesday and Wednesday (days 3 and 4) from the ACR annual meeting include: the important and impactful abstracts covered by the Rheumatology Roundup session; upadacitinib clinical trials; and the baricitinib CV and VTE safety analysis.

Read Article

Need for Pre-operative Hyperglycemia Testing Prior to Total Joint Replacement

Sep 10, 2019

JAMA reports on a large Medicare cohort study showing that amongst patients undergoing total joint replacement (TJR), preoperative HbA1c testing was performed in 26% to 43% of patients with diabetes and in only 5% of those without diabetes. Importantly research has shown that an elevated HbA1c

Read Article

Weight Loss Cuts Hospital Stays for Obese TKA Patients

Sep 04, 2019

Morbidly obese patients who lost 20 lbs before total knee arthroplasty (TKA) cut their hospital stays by about 1 day, and were 76% less likely to have an extended hospital stay, research showed. 

However, morbidly obese patients who lost between 5 and 10 lbs before the surgical

Read Article

A Potential Biomarker for Chronic Fatigue Syndrome Patients

Jul 17, 2019

Myalgic encephalomyelitis/chronic fatigue syndrome affects at least 2 million people in the United States and bears tremendous overlap with fibromyalgia - both being difficult to diagnosis because the symptom complex is often unrecognized and these conditions have no biomarker test. 

Read Article

RheumNow Podcast – Gout Spot Light (1.11.19)

Jan 11, 2019

Dr. Jack Cush discusses the highlights from the past week on RheumNow.com:

Read Article

Sleep Apnea Increases Gout Risk

Jan 02, 2019

Both Gout and obstructive sleep apnea (OSA) comingle with a wide range of serious comorbidities. A matched retrospective cohort study from the UK Clinical Practice Research database shows those with OSA are at a higher risk of developing gout.

This report compared 15,879 patients with

Read Article

Pre-Diabetes Associated Risk for Arthritis, Obesity and Physical Inactivity

Nov 13, 2018

The current MMWR reports that arthritis is seen in nearly one-third of adults with prediabetes and that more than half of such patients are obese and not engaged in regular physical activity.

Doctor-diagnosed arthritis affects 54.4 million in the U.S. and the CDC expects this to rise to

Read Article

Activity Trackers May be Helpful in Arthritis Patients

Oct 04, 2018

Use of wearable activity trackers was associated with increases in the number of daily steps among individuals with rheumatic and musculoskeletal disorders, a meta-analysis found.

In seven studies that assessed the number of daily steps during a mean study duration of 13.9 weeks, the

Read Article

Dietary Recommendations for Psoriatic Disease

Aug 21, 2018

A systematic review by the Medical Board of the National Psoriasis Foundation examined the role of diet in managing adult patients with psoriasis and/or psoriatic arthritis and suggest that dietary interventions to reduce disease severity.

A metanalysis of 55 studies and 4534 patients

Read Article

Severity of Lupus Nephritis is Declining over Time

May 08, 2018

A retrospective follow-up study of 499 lupus nephritis (LN) patients over three successive eras shows that LN has become less severe in recent years and thus, better long-term survival is possible.

A multicenter, Italian study examined LN patients over a 46-year period, dividing eras

Read Article

Rising Need for Weight Loss Counseling in Arthritic Patients

May 07, 2018

The CDC's May 4th MMWR reports that from 2002 to 2014, the prevalence of health care provider counseling for weight loss among adults with arthritis and overweight or obesity increased by 10% (from 35% to 45%).

Among the 54.4 million adults with doctor-diagnosed arthritis in the United

Read Article

Increased Comorbidity Burden in Lupus African Americans

Apr 11, 2018

Researchers from Vanderbilt University Medical Center used electronic health records (EHR) to perform a phenome-wide study comparing African American (AA-SLE) and Caucasian (C-SLE) with systemic lupus erythematosus (SLE) and found more comorbidities in AA-SLE, especially renal, cardiovascular

Read Article

Leflunomide May Sensitize the Insulin Receptor and Have an Anti-Glycemic Effect

Mar 05, 2018

An animal model study in the Journal of Endocrinololgy reports the potential use of leflunomide in the control of hyperglycemia in male mice. 

Read Article

Diet During Pregnancy May Influence Future Allergic or Autoimmune Disease

Mar 01, 2018

A systematic review of the literature on the relationship between diet during pregnancy, lactation, or the first year of life suggests that maternal ingestion of probiotic and fish oil supplementation may reduce risk of eczema and allergic sensitization to food, respectively.

Using the

Read Article

Gout Increases Risk of Stroke Moreso than MI

Oct 18, 2017

Gout coassociates with many of the disorders within the metabolic syndrome - diabetes, hypertension, hyperlipidemia and obesity.  Not surprisingly, gout is a risk factor for cardiovascular disease, but the risk magnitude for  myocardial infarction (MI), and stroke are unclear.

Singh and

Read Article

Consensus on OP Drug Holidays

Apr 24, 2017

Extending bisphosphonate treatment beyond 3–5 years does not confer additional benefit in low-risk populations. Treatment re-initiation (usually 1–3 years after bisphosphonate withdrawal) depends on risk factors, new fractures and bone mineral density. The evidence regarding denosumab

Read Article

Mortality in Gout Increased

Mar 30, 2017

Two current articles in the Journal of Rheumatology address issues surrounding mortality risk among those with new and established gout.

Vincent et al assessed predictors of mortality in patients with a recent onset of gout (disease duration

Read Article

Statins Don't Increase Risk of Colchicine Myopathy

Jan 12, 2017

Neuromyopathy is a rare side effect of chronic colchicine use. Statins are more commonly implicated as a cause of drug-induced myopathy.  

Given the frequent occurrence of the metabolic syndrome, simultaneous use of both colchicine and statins is common.

A Korean study compared

Read Article

DEXA Still Needed While on Bisphosphonates

Jul 20, 2016

Reuters reports that a study of 6629 Canadian women with osteoporosis taking bisphosphonates found that nearly one in five had a decrease in bone density while on medication. (Citation source: http://buff.ly/2afb7nj

The value of repeated DEXA (dual

Read Article
×